Dr. Soumya Basu, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, India.
Dr. Soumya Basu is a distinguished scientist and academic specializing in cancer and translational research. With a Ph.D. in Life Sciences and over 18 years of research experience, he has made significant contributions to understanding drug-resistant cancer and targeted therapies. His academic journey spans multiple disciplines, including microbiology, medical writing, and artificial intelligence applications in cancer research. As an Associate Professor at Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, he has played a pivotal role in scientific mentorship, research advancements, and cross-disciplinary collaborations. His expertise in molecular oncology, cell-based assays, and small molecule design has led to impactful research, widely recognized in the scientific community through publications and citations.
Profile
Google Scholar
Early Academic Pursuits 🎓
From an early stage, Dr. Soumya Basu exhibited a keen interest in the sciences, embarking on an academic journey that laid the foundation for an illustrious career in life sciences and cancer research. He earned a Bachelor of Science in Physics, Chemistry, and Mathematics from the University of Burdwan, followed by a Master’s degree in Microbiology from the University of Kalyani. His unwavering passion for research led him to pursue a Ph.D. in Life Sciences at Jadavpur University, focusing on reactive oxygen species-mediated targeted therapy in drug-resistant cancer. Further enhancing his expertise, he pursued an Advanced Diploma in Medical Writing and Regulatory Affairs and later completed an Advanced Postgraduate course in Artificial Intelligence and Machine Learning from the University of Texas at Austin, reinforcing his multidisciplinary approach to modern scientific research.
Professional Endeavors 🎮
Dr. Basu’s professional journey is marked by his dedication to academia and translational research. He currently serves as an Associate Professor and Principal Investigator at the Cancer and Translational Research Centre, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Pune. His tenure at Dr. D. Y. Patil Vidyapeeth spans over a decade, where he initially joined as an Assistant Professor before rising to his current role. Prior to this, he contributed significantly as a Research Associate at the Molecular Functional Imaging Laboratory, ACTREC, Tata Memorial Center, and held esteemed positions as a Senior Research Fellow at the Chittaranjan National Cancer Institute (CNCI) and a Project Assistant at Jadavpur University and the University of Calcutta. His early teaching career at Kulti College further highlights his commitment to education and mentorship.
Contributions and Research Focus 🧑�🔬
Dr. Basu’s research is deeply rooted in cancer therapeutics, particularly in drug-resistant malignancies. His work spans multiple domains, including animal cell culture, cell-based assays, small molecule design and validation, and non-coding RNA research. With a strong emphasis on translational research, he has been at the forefront of developing novel therapeutic strategies targeting drug-resistant cancer cells. His contributions to molecular oncology and biotechnology have paved the way for advancements in personalized medicine, integrating computational approaches like artificial intelligence and machine learning to enhance predictive models in cancer treatment.
Accolades and Recognition 🏆
Over his distinguished career, Dr. Basu has garnered widespread recognition for his contributions to scientific research. His prolific publication record, including books, book chapters, research articles, and technical reports, attests to his commitment to advancing knowledge in cancer biology. His Google Scholar profile boasts an H-index of 14, with over 550 citations, underscoring the impact of his research in the global scientific community. His expertise in scientific writing and editing has also made him a sought-after mentor and collaborator in academia.
Impact and Influence 📈
Dr. Basu’s work has had a profound impact on the field of oncology, with his research findings influencing therapeutic strategies and treatment paradigms. His mentorship and guidance have inspired numerous young researchers, fostering the next generation of scientists dedicated to battling cancer. His contributions extend beyond the laboratory, as he actively participates in knowledge dissemination through conferences, workshops, and academic collaborations. His ability to bridge the gap between fundamental research and clinical application has positioned him as a thought leader in the field.
Legacy and Future Contributions 🌟
As a scientist and educator, Dr. Basu’s legacy is defined by his relentless pursuit of innovation in cancer research. His ongoing work aims to refine targeted therapies, explore novel drug delivery systems, and harness artificial intelligence for more effective cancer diagnostics and treatment. With a vision to create a lasting impact on cancer care, he continues to drive transformative research initiatives. His unwavering commitment to scientific excellence ensures that his contributions will shape the future of oncology for years to come.
Publication
-
Synthesis, spectroscopic characterization, X-ray powder structure analysis, DFT study and in vitro anticancer activity of N-(2-methoxyphenyl)-3-methoxysalicylaldimine
- Authors: B Chattopadhyay, S Basu, P Chakraborty, SK Choudhuri, AK Mukherjee, …
- Year: 2009
-
Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate
- Authors: A Ganguly, S Basu, P Chakraborty, S Chatterjee, A Sarkar, M Chatterjee, …
- Year: 2010
-
Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach
- Authors: KB Lokhande, S Ballav, RS Yadav, KV Swamy, S Basu
- Year: 2022
-
Use of BRET to study protein–protein interactions in vitro and in vivo
- Authors: S Dimri, S Basu, A De
- Year: 2016
-
Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis
- Authors: A Ganguly, S Basu, K Banerjee, P Chakraborty, A Sarkar, M Chatterjee, …
- Year: 2011
-
PPAR-γ partial agonists in disease-fate decision with special reference to cancer
- Authors: S Ballav, B Biswas, VK Sahu, A Ranjan, S Basu
- Year: 2022
-
Drug repurposing—an emerging strategy in cancer therapeutics
- Authors: JA Khadija Shahab Turabi, Ankita Deshmukh, Sayan Paul, Dayanand Swami, S Basu
- Year: 2022
-
Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule study
- Authors: KB Lokhande, S Ballav, N Thosar, KV Swamy, S Basu
- Year: 2020
Conclusion 🌟
Dr. Soumya Basu’s career is a testament to his unwavering dedication to cancer research and academia. His contributions to targeted therapies, translational oncology, and biomedical advancements continue to influence both scientific understanding and clinical applications. Through his mentorship and research initiatives, he is shaping the next generation of scientists while driving forward innovative solutions for cancer treatment. With his ongoing efforts in integrating AI with biomedical sciences, Dr. Basu remains at the forefront of cutting-edge cancer research, ensuring a lasting impact on the field.